Gastrointestinal (GI) molecular assays for rapid, highly sensitive diagnostic tools that simultaneously detect bacterial, viral, and parasitic pathogens from stool samples

Use molecular syndromic STI panels to detect bacteria, viruses, and parasites from swab or urine samples.

Syndromic panels for respiratory molecular assays allow for simultaneous detection of a broad range of pathogens, reducing the need for multiple, individual tests from a single patient sample. Highly sensitive molecular diagnostic methods provide superior accuracy in identifying pathogens compared to traditional culture or antigen tests and shorter turn around times aiding timely clinical decisions

HPV molecular assays detect high-risk Human Papillomavirus (hrHPV) DNA or mRNA, serving as the primary screening tool for cervical cancer by identifying infection before cell abnormalities appear

Molecular assays for healthcare acquired infections (HAIs) providing rapid, highly sensitive detection of pathogens and resistance genes

Molecular assays for meningitis to provide rapid, sensitive identification of bacteria, viruses, and fungi from cerebrospinal fluid (CSF), often crucial when conventional cultures are negative due to prior antibiotic use. Multiplex PCR panels allow detection of multiple pathogens simultaneously and real-time PCR (rtPCR) for rapid, quantitative detection

Rapid nucleic acid amplification tests (NAATs) to detect M.tuberculosis DNA and multi-line drug resistance. Rapid turn around times compared with traditional culture.

Other highly sensitive molecular diagnostic assays to aid and inform clinical decision making.

Flexible & Automated Extraction Methods